SUBSTITUTED STRAIGHT CHAIN SPIRO DERIVATIVES

The present invention relates to pharmaceutical agents useful for therapy and/or prophylaxis in a mammal, pharmaceutical composition comprising such compounds, and their use as menin/MLL protein/protein interaction inhibitors, useful for treating diseases such as cancer, including but not limited to...

Full description

Saved in:
Bibliographic Details
Main Authors LI, Kangying, THURING, Johannes Wilhelmus John F, DARVILLE, Nicolas Freddy J, DAI, Xuedong, XU, Yanping, FANG, Lichao, FU, Liqiang, NG, Alicia Tee Fuay, URBANIETZ, Gregor Thomas, DENG, Xiangjun, MATON, William, Marc, ZHAO, Qiwu, LIU, Yingtao, PANDE, Vineet, CAI, Wei, QUEROLLE, Olivier Alexis Georges, CLEATOR, Edward, LIU, Lianzhu, LI, Ming
Format Patent
LanguageEnglish
French
German
Published 26.10.2022
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention relates to pharmaceutical agents useful for therapy and/or prophylaxis in a mammal, pharmaceutical composition comprising such compounds, and their use as menin/MLL protein/protein interaction inhibitors, useful for treating diseases such as cancer, including but not limited to leukemia, myelodysplastic syndrome (MDS), and myeloproliferative neoplasms (MPN); and diabetes.
Bibliography:Application Number: EP20200902289